Genomic Markers Before and After Treatment of Actinic Keratosis With Imiquimod 3.75% Cream

NCT03914417 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Actinic Keratosis

Interventions

DRUG: Imiquimod 3.75% Cream

Sponsor

Icahn School of Medicine at Mount Sinai

Collaborators

[object Object]